Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Equity (Deficit)

v3.23.1
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Contingently Redeemable Convertible Common Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2021 [1]   114,795,000 0      
Temporary equity, balances at beginning of period at Dec. 31, 2021 [1]   $ 487,918 $ 0      
Increase (Decrease) in Temporary Equity [Roll Forward]            
Issuance of convertible common stock (in shares) [1]     2,750,000      
Issuance of convertible common stock [1]     $ 27,473      
Temporary equity, balances at ending of period (in shares) at Mar. 31, 2022 [1]   114,795,000 2,750,000      
Temporary equity, balances at ending of period at Mar. 31, 2022 [1]   $ 487,918 $ 27,473      
Balances at beginning of period (in shares) at Dec. 31, 2021 [1]       9,368,000    
Balances at beginning of period at Dec. 31, 2021 $ (456,279)     $ 1 [1] $ 33,863 $ (490,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) [1]       87,000    
Issuance of common stock upon exercise of stock options 171       171  
Reduction in transaction costs 0          
Vesting of early exercise of options 125       125  
Stock-based compensation 4,501       4,501  
Net loss (47,384)         (47,384)
Balances at ending of period (in shares) at Mar. 31, 2022 [1]       9,455,000    
Balances at ending of period at Mar. 31, 2022 $ (498,866)     $ 1 [1] 38,660 (537,527)
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2022 0          
Temporary equity, balances at beginning of period at Dec. 31, 2022 $ 0          
Temporary equity, balances at ending of period (in shares) at Mar. 31, 2023 0          
Temporary equity, balances at ending of period at Mar. 31, 2023 $ 0          
Balances at beginning of period (in shares) at Dec. 31, 2022       177,857,000    
Balances at beginning of period at Dec. 31, 2022 $ 26,533     $ 18 604,373 (577,858)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) 178,564     179,000    
Issuance of common stock upon exercise of stock options $ 68       68  
Cancellation of Earn-Out Shares (in shares) (985,722)     (986,000)    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)       1,695,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings $ (356)       (356)  
Reduction in transaction costs 9,609       9,609  
Stock-based compensation 4,915       4,915  
Net loss (13,069)         (13,069)
Balances at ending of period (in shares) at Mar. 31, 2023       178,745,000    
Balances at ending of period at Mar. 31, 2023 $ 27,700     $ 18 $ 618,609 $ (590,927)
[1] (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement